Background and Objective Obstructive sleep apnea (OSA) and stroke share a bidirectional relationship, where OSA increases stroke risk, and stroke predisposes patients to OSA. Continuous positive airway pressure (CPAP) is the gold standard therapy for OSA. This systematic review and meta-analysis aims to determine the effect of CPAP therapy on clinical outcomes in stroke patients with OSA.Methods Literature was searched in PubMed, ScienceDirect, and Taylor secondary outcomes included cognitive function, balance, depression, cardiovascular events and mortality, apnea-hypopnea index (AHI), and sleepiness.Results Six randomized controlled trials involving 349 patients (180 CPAP, 169 control) were included. Mean nightly CPAP use was 4.35 hours (95% confidence interval CI: 3.41 to 5.29), with a higher dropout rate in the CPAP group (risk ratio=5.41; 95% CI: 2.19 to 13.39; p=0.0003). CPAP did not significantly improve functional status (standardized mean difference SMD=0.46; 95% CI: -0.08 to 1.00; p=0.10) or neurological function (SMD=1.18; 95% CI: -0.35 to 2.70; p=0.13), both with high heterogeneity. However, CPAP significantly reduced AHI (mean difference=-21.31; 95% CI: -33.14 to -9.47; p=0.0004) and sleepiness (SMD=-1.43; 95% CI: -2.76 to -0.10; p=0.04).Conclusions Current evidence shows that CPAP improves OSA-specific parameters but remains insufficient to demonstrate benefits in stroke-related clinical outcomes. Larger, long-term studies with earlier CPAP initiation and evaluation of alternative treatments are needed.
Syafirah et al. (Tue,) studied this question.